Walgreens Boots Alliance, INC 10-Q quarterly reports
Quarterly reports, with unaudited financial statements and management’s discussion of the quarter just ended.
Walgreens Boots Alliance reported a reduced net loss for the nine months ended May 31, 2025, driven by lower impairment charges, but saw declines in adjusted earnings and U.S. retail sales, as the company progresses with its Footprint Optimization Program and a proposed merger.
10-Q: Walgreens Boots Alliance Reports Q2 2025 Results, Announces Merger Agreement and Dividend Suspension
Walgreens Boots Alliance (WBA) reported its Q2 2025 results, highlighted by a merger agreement with Blazing Star Parent, LLC, and the suspension of its quarterly dividend.
Walgreens Boots Alliance reports a net loss for Q1 2025, driven by restructuring costs and fair value adjustments, while advancing strategic initiatives to optimize its footprint and stabilize pharmacy margins.
Walgreens Boots Alliance's Q3 results show a mixed performance with a significant goodwill impairment charge impacting overall profitability, while cost-saving initiatives and U.S. Healthcare improvements offer some positives.
Walgreens Boots Alliance reported a significant net loss for the second quarter of 2024, primarily due to a substantial goodwill impairment charge related to its VillageMD investment.